(1 S-cis )-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro- N -methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate SERTRALINE STEP 2 612-243-00-5
Name
(1 S-cis )-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro- N -methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate SERTRALINE STEP 2 612-243-00-5
Molecular Formula
C25H25Cl2NO3
Identifiers
cas number 79617-97-3 PRIMARY
ec number 420-560-3
chemical name (1S-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate
chemical name cis-(1s,4s)-n-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine mandelate
chemical name (1 S-cis )-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro- N -methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate SERTRALINE STEP 2 612-243-00-5
GHS Hazard Pictograms
Hazard Classifications
Eye Dam. 1
Danger
Serious eye damage
Hazard Code: H318
Category: Eye Dam. 1
Source: Harmonised C&L
Aquatic Acute 1
Hazardous to the aquatic environment (acute)
Hazard Code: H400
Category: Aquatic Acute 1
Source: Harmonised C&L
Aquatic Chronic 1
Hazardous to the aquatic environment (long-term)
Hazard Code: H410
Category: Aquatic Chronic 1
Source: Harmonised C&L
Regulatory Lists (1)
KEMI PRIO PHASE-OUT SUBSTANCES
KEMI PRIO Phase-Out Substances — Swedish Chemicals Agency list of substances with properties of very high concern that should be phased out
Disclaimer
The substance data provided is sourced from various third-party databases and regulatory sources. While we strive to maintain accuracy, we cannot guarantee the completeness, accuracy, or timeliness of this information. Users are responsible for verifying all data before use in compliance, safety, or regulatory contexts. NextSDS is not liable for any decisions made based on this data.